John Conrad Otto
John Conrad Otto (1774–1844) was an American physician known for his contributions to the understanding of hemophilia. He was one of the first to describe the hereditary nature of the disease and its prevalence in certain families.
Early Life and Education[edit | edit source]
John Conrad Otto was born in Woodbridge Township, New Jersey in 1774. He pursued his medical education at the University of Pennsylvania, where he graduated in 1798. Otto was influenced by prominent physicians of his time, including Benjamin Rush.
Medical Career[edit | edit source]
After completing his education, Otto began practicing medicine in Philadelphia, Pennsylvania. He quickly gained a reputation for his clinical skills and dedication to patient care. Otto's most significant contribution to medicine was his research on hemophilia, a condition that was poorly understood at the time.
Research on Hemophilia[edit | edit source]
In 1803, Otto published a paper titled "An Account of an Hemorrhagic Disposition Existing in Certain Families," in which he described the hereditary nature of hemophilia. He noted that the condition primarily affected males and was passed down through female carriers. Otto's work laid the foundation for future research on the genetic basis of hemophilia and its transmission patterns.
Legacy[edit | edit source]
John Conrad Otto's pioneering work on hemophilia earned him recognition as a leading figure in early American medicine. His observations and documentation of the disease contributed significantly to the understanding of its genetic nature. Otto continued to practice medicine in Philadelphia until his death in 1844.
Related Pages[edit | edit source]
- Hemophilia
- Benjamin Rush
- University of Pennsylvania
- Philadelphia, Pennsylvania
- Woodbridge Township, New Jersey
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD